Autophagy and its role in osteosarcoma
Open Access
- 15 February 2023
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 12 (5) , 5676-5687
Abstract
Osteosarcoma (OS) is the most common bone malignancy and preferably occurs in children and adolescents. Despite significant advances in surgery and chemotherapy for OS over the past few years, overall survival rates of OS have reached a bottleneck. Thus, extensive researches aimed at developing new therapeutic targets for OS are urgently needed. Autophagy, a conserved process which allows cells to recycle altered or unused organelles and cellular components, has been proven to play a critical role in multiple biological processes in OS. In this article, we summarized the association between autophagy and proliferation, metastasis, chemotherapy, radiotherapy, and immunotherapy of OS, revealing that autophagy‐related genes and pathways could serve as potential targets for OS therapy.Keywords
This publication has 111 references indexed in Scilit:
- Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and AutophagyCell, 2013
- Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagyMolecular Biology of the Cell, 2012
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- The Role of Autophagy in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 2011
- Astrocyte elevated gene-1 induces protective autophagyProceedings of the National Academy of Sciences, 2010
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Autophagy and aging: keeping that old broom workingTrends in Genetics, 2008
- The Atg8 and Atg12 ubiquitin‐like conjugation systems in macroautophagyEMBO Reports, 2008
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomesJournal of Cell Science, 2006